Introduction: Racial and ethnic disparities in orthopaedic surgery are well documented. However, the extent to which these persist in fracture care is unknown. This study sought to assess racial disparities in the postoperative surgical and medical management of patients after diaphyseal tibia fracture fixation., Methods: Patients with surgically treated tibial shaft fractures from October 1, 2015, to December 31, 2020, were identified in the MarketScan® Medicaid Database. Exclusion criteria included concurrent fractures or amputation. Outcomes included 2-year postoperative complications, reoperation rates, and filled prescriptions. Surgically-treated Black and White cohorts were propensity-score matched using nearest-neighbor matching on patient demographics, comorbidities, fracture pattern and severity, and fixation type. Chi-square tests and survival analyses (Kaplan-Meier and Cox proportional hazard models) were conducted., Results: 5,472 patients were included, 2,209 Black and 3,263 White patients. After matching, 2,209 were retained in each cohort. No significant differences in complication rates were observed in the matched Black vs White cohorts. Rates of reoperation, however, were significantly lower in Black as compared to White patients (28.5 % vs. 35.5 % rate, risk difference = 7.0 % (95 % confidence interval (CI): 4.2 % to 9.7 %)). Implant removal was also significantly lower in Black (17.9 %) vs. White (25.1 %) patients (Risk difference = 7.2 %, (95 %CI: 4.8 % to 9.6 %)). The adjusted hazard ratio comparing the reoperation rate in Black versus White patients was 0.77 (95 %CI: 0.69-0.82, p < 0.0001). Significantly lower proportions of Black vs White patients filled at least one prescription for benzodiazepine, antidepressants, strong opiates, or antibiotics at every time point post-index., Discussion: Fewer resources were used in post-operative management after surgical treatment of tibial shaft fractures for Black versus White Medicaid-insured patients. These results may be reflective of the undertreatment of complications after tibia fracture surgery for Black patients and highlight the need for further interventions to address racial disparities in trauma care., Competing Interests: Declaration of competing interest MRDB has the following disclosures: Azra Care: Stock or stock Options; DePuy, A Johnson & Johnson Company: Research support; Next Science: Paid consultant; Research support; NSite: Stock or stock Options; Orthopaedic Trauma Association: Board or committee member; Reselute: IP royalties; Paid consultant; Stock or stock Options; Shukla: IP royalties; Paid consultant; SI Bone: Paid consultant; Paid presenter or speaker; Synthes: Paid consultant; Paid presenter or speaker; Wolters Kluwer Health - Lippincott Williams & Wilkins: Publishing royalties, financial or material support. MV, CEH, JWR, AP, MV and PMC have the following disclosures: Employees of DePuy/Johnson & Johnson, receiving salary/stock from Johnson & Johnson. TMML has nothing to disclose. CAP has the following disclosures: Arthrex, Inc: Paid presenter or speaker; Azra Care Inc.: Paid consultant; Stock or stock Options; Kaizen Clinical Partners: Paid consultant., (Copyright © 2024. Published by Elsevier Ltd.)